PRINCETON, NJ, UNITED STATES, October 28, 2024 /EINPresswire / -- SHINKEI Therapeutics, a clinical-stage Pharmaceutical company dedicated to developing treatments for central nervous system (CNS ...
Numerous studies have shown that medications in combination with psychotherapy yield the best treatment outcomes. If you have been searching for a provider with dual expertise in these critical ...
Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...
Two pioneering digital therapeutics (DTx) for addiction are available once again after their original developer Pear Therapeutics was dissolved last year. The AI effect in pharma commercial ...
Therapeutics are treatments used to alleviate or prevent a particular disease. Examples of therapeutics include drug therapy, medical devices, nutrition therapy and stem-cell therapies ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TScan Therapeutics (TCRX – Research ...
1 Day NTLA -3.24% DJIA 0.11% S&P Mid Cap 400 -0.53% Health Care/Life Sciences -0.43% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...
BERLIN--(BUSINESS WIRE)--Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines to treat neurodegenerative and other diseases, launched today with ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--City Therapeutics, Inc. announced its launch today with a vision to lead the future of RNA interference (RNAi)-based medicine. City Therapeuticsâ„¢ aims to ...
Live webcasts of the presentations will be available via the Events & Presentations page in the Investors section of ADC Therapeutics' website, ir.adctherapeutics.com. A replay of each webcast ...
MONTREAL, Oct. 21, 2024 /CNW/ - Find Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced ...